No abstract available
Publication types
-
Case Reports
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Autoantibodies / metabolism
-
Chromosome Disorders
-
DNA Mutational Analysis
-
Family
-
Genes, Dominant
-
Hemorrhage
-
Humans
-
Janus Kinase 2 / genetics
-
Male
-
Mutation / genetics
-
Myeloproliferative Disorders / complications
-
Myeloproliferative Disorders / diagnosis*
-
Myeloproliferative Disorders / drug therapy
-
Myeloproliferative Disorders / genetics
-
Myeloproliferative Disorders / physiopathology
-
Pedigree
-
Platelet Aggregation / genetics
-
Platelet Aggregation Inhibitors / administration & dosage
-
Remission Induction
-
Thrombocythemia, Essential / complications
-
Thrombocythemia, Essential / diagnosis*
-
Thrombocythemia, Essential / drug therapy
-
Thrombocythemia, Essential / genetics
-
Thrombocythemia, Essential / physiopathology
-
von Willebrand Disease, Type 1 / complications
-
von Willebrand Disease, Type 1 / diagnosis*
-
von Willebrand Disease, Type 1 / drug therapy
-
von Willebrand Disease, Type 1 / genetics
-
von Willebrand Disease, Type 1 / physiopathology
-
von Willebrand Disease, Type 2 / complications
-
von Willebrand Disease, Type 2 / diagnosis*
-
von Willebrand Disease, Type 2 / drug therapy
-
von Willebrand Disease, Type 2 / genetics
-
von Willebrand Disease, Type 2 / physiopathology
-
von Willebrand Factor / genetics
-
von Willebrand Factor / immunology
-
von Willebrand Factor / metabolism*
Substances
-
Autoantibodies
-
Platelet Aggregation Inhibitors
-
von Willebrand Factor
-
JAK2 protein, human
-
Janus Kinase 2